NovantaNOVT
About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Employees: 3,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
32% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 100
5% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 43
0% less capital invested
Capital invested by funds: $4.52B [Q1] → $4.51B (-$5.67M) [Q2]
1.01% less ownership
Funds ownership: 98.22% [Q1] → 97.22% (-1.01%) [Q2]
2% less funds holding
Funds holding: 321 [Q1] → 316 (-5) [Q2]
85% less call options, than puts
Call options by funds: $247K | Put options by funds: $1.7M
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Baird Robert Mason | 12%upside $133 | Neutral Maintained | 11 Aug 2025 |
Financial journalist opinion
Based on 5 articles about NOVT published over the past 30 days









